Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy

被引:50
作者
Bohlega, S
Abu-Amero, SN
Wakil, SM
Carroll, P
Al-Amr, R
Lach, B
Al-Sayed, Y
Cupler, EJ
Meyer, BF
机构
[1] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia
关键词
D O I
10.1212/01.WNL.0000123255.92062.37
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To identify the gene and specific mutation underlying hyaline body myopathy in the family studied. Methods: A microsatellite-based whole genome scan was performed. Linkage analysis assumed autosomal dominant inheritance and equal allele frequencies. A candidate gene approach within the linked interval and direct sequencing were used for mutation detection. Results: Initial analysis indicated a maximum lod score of 3.01 at D14S1280. High-density mapping surrounding the linked locus was performed. Multipoint analysis showed that the linked region with a maximum lod score of 3.01 extended from D14S742 to D14S608 with a peak non-parametric linkage (NPL) score of 3.75 at D14S608. The myosin heavy chain genes MYH6 and MYH7 map to the region between D14S742 and D14S1280. Sequence analysis of the coding regions of MYH7 revealed an A-->T transversion at nucleotide position 25596 (M57965) resulting in a histidine-to-leucine amino acid change at residue 1904 (H1904L). Conclusion: Pathogenicity of the MYH7 H1904L mutation most likely results from disruption of myosin heavy chain assembly or stability of the sarcomeric protein. The MYH7 tail domain mutation results in an inclusion body myopathy with an apparent absence of hypertrophic cardiomyopathy usually associated with mutations of this gene.
引用
收藏
页码:1518 / 1521
页数:4
相关论文
共 19 条
[1]  
Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K
[2]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[3]   HYALINE BODY MYOPATHY [J].
BAROHN, RJ ;
BRUMBACK, RA ;
MENDELL, JR .
NEUROMUSCULAR DISORDERS, 1994, 4 (03) :257-262
[4]   Mutations of the light meromyosin domain of the β-myosin heavy chain rod in hypertrophic cardiomyopathy [J].
Blair, E ;
Redwood, C ;
Oliveira, MD ;
Moolman-Smook, JC ;
Brink, P ;
Corfield, VA ;
Östman-Smith, I ;
Watkins, H .
CIRCULATION RESEARCH, 2002, 90 (03) :263-269
[5]   Autosomal dominant hyaline body myopathy - Clinical variability and pathologic findings [J].
Bohlega, S ;
Lach, B ;
Meyer, BF ;
Al Said, Y ;
Kambouris, M ;
Al Homsi, M ;
Cupler, EJ .
NEUROLOGY, 2003, 61 (11) :1519-1523
[6]   FAMILIAL MYOPATHY WITH PROBABLE LYSIS OF MYOFIBRILS IN TYPE-I FIBERS [J].
CANCILLA, PA ;
KALYANARAMAN, K ;
VERITY, MA ;
MUNSAT, T ;
PEARSON, CM .
NEUROLOGY, 1971, 21 (06) :579-+
[7]  
CEUTERICK C, 1993, CLIN NEUROPATHOL, V12, P79
[8]   A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J].
GEISTERFERLOWRANCE, AAT ;
KASS, S ;
TANIGAWA, G ;
VOSBERG, HP ;
MCKENNA, W ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1990, 62 (05) :999-1006
[9]   FORCE MEASUREMENTS BY MICROMANIPULATION OF A SINGLE ACTIN FILAMENT BY GLASS NEEDLES [J].
KISHINO, A ;
YANAGIDA, T .
NATURE, 1988, 334 (6177) :74-76
[10]  
Kruglyak L, 1996, AM J HUM GENET, V58, P1347